Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies

被引：0
|
作者：
Mease, Philip [1 ,2 ]
Tillett, William [3 ,4 ]
de Wit, Maarten [5 ]
Gossec, Laure [6 ]
Husni, M. Elaine [7 ]
Proft, Fabian [9 ,10 ]
Ink, Barbara [8 ,11 ]
Bajracharya, Rajan [11 ]
Coarse, Jason [12 ]
Lambert, Jeremy [13 ]
Coates, Laura [14 ]
Gottlieb, Alice [15 ]
机构：
[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Royal Natl Hosp Rheumat Dis, Bath, England
[4] Univ Bath, Dept Life Sci, Ctr Therapeut Innovat, Bath, England
[5] Stichting Tools, Patient Res Partner, Amsterdam, Netherlands
[6] Sorbonne Univ, Paris, France
[7] Cleveland Clin, Cleveland, OH USA
[8] Charite Univ Med Berlin, Berlin, Germany
[9] Free Univ Berlin, Berlin, Germany
[10] Humboldt Univ, Berlin, Germany
[11] UCB Pharma, Slough, England
[12] UCB Pharma, Morrisville, NC USA
[13] UCB Pharma, Colombes, France
[14] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[15] Icahn Sch Med Mt Sinai, Dept Dermatol, Seattle, WA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2368
引用
收藏
页码：4789 / 4792
页数：4
相关论文
共 50 条
  • [41] Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies
    Husni, M. Elaine
    Mease, Philip J.
    Merola, Joseph F.
    Tillett, William
    Goldammer, Nadine
    Ink, Barbara
    Coarse, Jason
    Lambert, Jeremy
    Taieb, Vanessa
    Gladman, Dafna D.
    RMD OPEN, 2024, 10 (03):
  • [42] SUSTAINED AND CONSISTENT EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS REGARDLESS OF PRIOR TNF-INHIBITOR STATUS: RESULTS FROM THE PHASE 3 BE OPTIMAL AND BE COMPLETE TRIALS
    Tillett, William R.
    Ink, Barbara
    Bajracharya, Rajan
    Taieb, Vanessa
    Sharma, Poonam
    McGonagle, Dennis
    Coates, Laura C.
    McInnes, Iain B.
    RHEUMATOLOGY, 2024, 63
  • [43] BIMEKIZUMAB LONG-TERM SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM BE AGILE AND BE ACTIVE
    Poddubnyy, D.
    Mease, P.
    Warren, R. B.
    Gensler, L. S.
    Fleurinck, C.
    Ink, B.
    Oortgiesen, M.
    Vaux, T.
    Coarse, J.
    Assudani, D.
    Bajracharya, R.
    Deodhar, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1229 - 1231
  • [44] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL
    Mease, P. J.
    Kavanaugh, A.
    Reimold, A.
    Tahir, H.
    Rech, J.
    Hall, S.
    Geusens, P.
    Pascale, P.
    Delicha, E. M.
    Pricop, L.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 952 - 953
  • [45] Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
    Baraliakos, Xenofon
    Ranza, Roberto
    Ostor, Andrew
    Ciccia, Francesco
    Coates, Laura C.
    Rednic, Simona
    Walsh, Jessica A.
    Douglas, Kevin
    Gao, Tianming
    Kato, Koji
    Song, In-Ho
    Ganz, Fabiana
    Deodhar, Atul
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [46] Secukinumab Provides Clinical Improvements in Patients with Active Oligoarticular Psoriatic Arthritis: Results from a Pooled Analysis of 5 Phase 3 Studies
    Ogdie, Alexis
    Gladman, Dafna
    Coates, Laura
    Pournara, Effie
    Meng, Xiangyi
    Parikh, Bhumik
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3812 - 3815
  • [47] SECUKINUMAB PROVIDES CLINICAL IMPROVEMENTS IN PATIENTS WITH ACTIVE OLIGOARTICULAR PSORIATIC ARTHRITIS: RESULTS FROM A POOLED ANALYSIS OF FIVE PHASE 3 STUDIES
    Coates, Laura C.
    Ogdie, Alexis
    Gladman, Dafna D.
    Pournara, Effie
    Meng, Xiangyi
    Parikh, Bhumik
    Mease, Philip J.
    RHEUMATOLOGY, 2022, 61
  • [48] Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
    Xenofon Baraliakos
    Roberto Ranza
    Andrew Östör
    Francesco Ciccia
    Laura C. Coates
    Simona Rednic
    Jessica A. Walsh
    Kevin Douglas
    Tianming Gao
    Koji Kato
    In-Ho Song
    Fabiana Ganz
    Atul Deodhar
    Arthritis Research & Therapy, 25
  • [49] Patient-Reported Symptoms Improved with Stringent Control of Swollen Joints in Patients with Psoriatic Arthritis: Results from Two Phase 3 Studies of Bimekizumab
    Husni, M. Elaine
    Mease, Philip
    Gladman, Dafna
    Ink, Barbara
    Lambert, Jeremy
    Healy, Patrick
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2996 - 2999
  • [50] Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
    Mease, Philip J.
    Asahina, Akihiko
    Gladman, Dafna D.
    Tanaka, Yoshiya
    Tillett, William
    Ink, Barbara
    Assudani, Deepak
    de la Loge, Christine
    Coarse, Jason
    Eells, Jason
    Gossec, Laure
    RHEUMATOLOGY, 2023, 62 (02) : 617 - 628
12345